Page last updated: 2024-11-05

n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine and Retinal Degeneration

n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine has been researched along with Retinal Degeneration in 1 studies

N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine: a zinc ion chelating agent; structure given in first source
N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine : An N-substituted diamine that is ethylenediamine in which the four amino hydrogens are replaced by 2-pyridylmethyl groups.

Retinal Degeneration: A retrogressive pathological change in the retina, focal or generalized, caused by genetic defects, inflammation, trauma, vascular disease, or aging. Degeneration affecting predominantly the macula lutea of the retina is MACULAR DEGENERATION. (Newell, Ophthalmology: Principles and Concepts, 7th ed, p304)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choi, JS1
Kim, KA1
Yoon, YJ1
Fujikado, T1
Joo, CK1

Other Studies

1 other study available for n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine and Retinal Degeneration

ArticleYear
Inhibition of cyclooxygenase-2 expression by zinc-chelator in retinal ischemia.
    Vision research, 2006, Volume: 46, Issue:17

    Topics: Animals; Chelating Agents; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Edetic Acid; Ethylenediami

2006